As NLRX1 seems to be downregulated in the heart from acute myocardial infarction (AMI) (9), the activation of NLRX1 by novel compounds (34) may offer new therapeutic option to protect patients from myocardial infarction. Here, NLRX1 is linked to acute myocardial infarction.